163 related articles for article (PubMed ID: 10331560)
1. Comparison of basophil histamine releasability between atopic and nonatopic asthmatics.
Son JW; Kim YK; Chung JW; Lee SR; Cho SH; Min KU; Koh YY; Kim YY
J Korean Med Sci; 1999 Apr; 14(2):153-8. PubMed ID: 10331560
[TBL] [Abstract][Full Text] [Related]
2. Human basophil releasability. VI. Changes in basophil releasability in patients with allergic rhinitis or bronchial asthma.
Casolaro V; Spadaro G; Marone G
Am Rev Respir Dis; 1990 Nov; 142(5):1108-11. PubMed ID: 1700653
[TBL] [Abstract][Full Text] [Related]
3. Linkage between IgE receptor-mediated histamine releasability from basophils and gene marker of chromosome 11q13.
Kim YK; Cho SH; Koh YY; Son JW; Lee BJ; Min KU; Kim YY
J Allergy Clin Immunol; 1999 Sep; 104(3 Pt 1):618-22. PubMed ID: 10482837
[TBL] [Abstract][Full Text] [Related]
4. Human basophil releasability. III. Genetic control of human basophil releasability.
Marone G; Poto S; Celestino D; Bonini S
J Immunol; 1986 Dec; 137(11):3588-92. PubMed ID: 2431036
[TBL] [Abstract][Full Text] [Related]
5. Basophil releasability in the newborn: factors limiting immunoglobulin E-mediated histamine release.
Mendoza GR; Minagawa K; Orner FB; Stiehm ER
Pediatrics; 1982 Feb; 69(2):188-92. PubMed ID: 6173838
[TBL] [Abstract][Full Text] [Related]
6. Study of IgE-dependent basophil releasability in allergic patients.
Sanz ML; Latasa M; García BE; Gato JJ; Oehling A
J Investig Allergol Clin Immunol; 1991 Oct; 1(5):293-301. PubMed ID: 1727011
[TBL] [Abstract][Full Text] [Related]
7. Allergen-specific conventional immunotherapy decreases immunoglobulin E-mediated basophil histamine releasability.
Shim JY; Kim BS; Cho SH; Min KU; Hong SJ
Clin Exp Allergy; 2003 Jan; 33(1):52-7. PubMed ID: 12534549
[TBL] [Abstract][Full Text] [Related]
8. Basophil histamine release and leukotriene production in response to anti-IgE and anti-IgE receptor antibodies. Comparison of normal subjects and patients with urticaria, atopic dermatitis or bronchial asthma.
Bischoff SC; Zwahlen R; Stucki M; Müllner G; de Weck AL; Stadler BM; Dahinden CA
Int Arch Allergy Immunol; 1996 Jul; 110(3):261-71. PubMed ID: 8688673
[TBL] [Abstract][Full Text] [Related]
9. Human basophil releasability. VIII. Increased basophil releasability in patients with scleroderma.
de Paulis A; Valentini G; Spadaro G; Lupoli S; Tirri G; Marone G
Arthritis Rheum; 1991 Oct; 34(10):1289-96. PubMed ID: 1718285
[TBL] [Abstract][Full Text] [Related]
10. Histamine release and morphological changes in basophilic granulocytes of atopic asthmatics induced by antigen, anti-IgE and Ca ionophore A 23187.
Tanizaki Y; Nakagawa S; Kimura I
Arerugi; 1992 May; 41(5):571-6. PubMed ID: 1381575
[TBL] [Abstract][Full Text] [Related]
11. Human basophil releasability. II. Changes in basophil releasability in patients with atopic dermatitis.
Marone G; Giugliano R; Lembo G; Ayala F
J Invest Dermatol; 1986 Jul; 87(1):19-23. PubMed ID: 2425005
[TBL] [Abstract][Full Text] [Related]
12. Enhanced IgE-dependent basophil histamine release and airway reactivity in asthma.
Gaddy JN; Busse WW
Am Rev Respir Dis; 1986 Nov; 134(5):969-74. PubMed ID: 3096179
[TBL] [Abstract][Full Text] [Related]
13. Ionic regulation of human basophil releasability. III. Effects of Na+ and Ca2+ on histamine release induced by different stimuli.
Tedeschi A; Palella M; Arquati M; Milazzo N; Miadonna A
Pharmacol Res; 1994; 30(3):229-41. PubMed ID: 7532302
[TBL] [Abstract][Full Text] [Related]
14. Enhanced basophil releasability in subjects infected with human immunodeficiency virus.
Miadonna A; Leggieri E; Tedeschi A; Lazzarin A; Chianura L; Froldi M; Zanussi C
Clin Immunol Immunopathol; 1990 Feb; 54(2):237-46. PubMed ID: 1688523
[TBL] [Abstract][Full Text] [Related]
15. In vivo characterization of the anti-inflammatory effect of cyclosporin A on human basophils.
Casolaro V; Spadaro G; Patella V; Marone G
J Immunol; 1993 Nov; 151(10):5563-73. PubMed ID: 7693814
[TBL] [Abstract][Full Text] [Related]
16. Functional evaluation of the basophil/IgE system in the cord blood.
Miadonna A; Tedeschi A; Leggieri E; Motta G; Fabbri C; Froldi M; Agosti M; Lorini M; Marini A; Zanussi C
Int Arch Allergy Appl Immunol; 1986; 81(3):276-83. PubMed ID: 2429932
[TBL] [Abstract][Full Text] [Related]
17. Ionic regulation of human basophil releasability. I. Inhibitory effect of copper.
Tedeschi A; Arquati M; Lorini M; Milazzo N; Miadonna A
Agents Actions; 1992 Sep; 37(1-2):16-24. PubMed ID: 1280906
[TBL] [Abstract][Full Text] [Related]
18. Basophil "releasability" in patients with asthma.
Findlay SR; Lichtenstein LM
Am Rev Respir Dis; 1980 Jul; 122(1):53-9. PubMed ID: 6157344
[TBL] [Abstract][Full Text] [Related]
19. Human basophil/mast cell releasability. V. Functional comparisons of cells obtained from peripheral blood, lung parenchyma, and bronchoalveolar lavage in asthmatics.
Casolaro V; Galeone D; Giacummo A; Sanduzzi A; Melillo G; Marone G
Am Rev Respir Dis; 1989 Jun; 139(6):1375-82. PubMed ID: 2471428
[TBL] [Abstract][Full Text] [Related]
20. Defective inhibition of sodium on basophil histamine release in patients with allergic rhinitis and bronchial asthma.
Tedeschi A; Cottini M; Salmaso C; Milazzo N; Miadonna A
Eur Respir J; 1996 Oct; 9(10):2070-6. PubMed ID: 8902469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
